Why Buy Amino Acids?

If you want your body to operate at peak physical condition, then you need to ensure that your nutrition is carefully crafted, well looked after, and laser-focused on supporting your body’s needs.

A significant part of managing your physical and mental health depends on amino acids responsible for forming critically essential proteins in your body. These proteins perform a wide array of functions in the body.

However, if you can’t get them through your diet, you may want to buy amino acids from reputable suppliers like us at Sunshine Biopharma Nutrition. Let’s take a look at some of the reasons you might want to buy amino acids.

Inadequate Diet

There are many reasons why your diet might not be capable of providing you with all of the amino acids your body needs to remain strong and healthy.

In many cases, it is simply a matter of not having enough time to prepare the right kinds of foods every day. It is so much easier just to eat junk food because it’s quick and easy. Healthy foods such as whole foods can also be relatively expensive compared to much cheaper processed foods.

Some people don’t get enough nutrition because they suffer from conditions that prevent them from getting everything they need. These conditions could range from bulimia and anorexia to pregnancy and old age.

Whatever the case, buying amino acid supplements can make a difference, providing you with the health boost your body needs at a fraction of the cost, time and effort involved in trying to get all of it into your body through your diet every day.

Get A Boost

In some cases, illness can ravage your body of the nutrients it needs to stay healthy. So to speed up recovery, your body needs amino acids to grow stronger and fight off future infections and viruses.

In other cases, you might need a performance booster because you’re training, bodybuilding, competing in some sport or writing examinations. You want to be in good shape for these activities, so amino acids are essential. Amino acids will help you build and retain muscle, improve your memory, reduce fatigue and help you become more supple.

If you want to buy amino acids, contact Sunshine Biopharma Nutrition today!

Why Biopharma Is Changing The Face Of Medicine Today

As one of the most exciting emerging biopharma companies in Canada, we at Sunshine Biopharma Nutrition are at the forefront of the biopharma revolution.

Biopharma is all about using advanced biotechnology to extract living organisms and organic components ‒ such as sugars, proteins, amino acids, nucleic acids and more ‒ from biological sources, such as people, animals or plants, to synthesize medicines and supplements. The products manufactured through biopharma are identical to naturally occurring products found in nature, which is why they are so effective.

Medicines

Biopharmaceuticals are changing the way we understand and use medicine. Conditions such as cardiovascular disease, cancer, diabetes and even HIV are being treated with biopharmaceuticals with great success and minimal to no side effects.

Biopharma is not made using an array of potentially harmful chemicals the way normal pharmaceuticals are made. Regular pharmaceuticals can have devastating side effects on the human body, especially if used for extended periods.

Moreover, regular pharmaceuticals can be extremely expensive and, in many cases, dependencies tend to form, leading to problems later on.

Biopharma is highly effective at preventing health problems from occurring in the first place, while also being very useful in treating and managing various conditions.

Supplements

Aside from an array of medicines, biopharma is responsible for providing numerous nutritional supplements, from protein powders to amino acid supplements and everything in between.

These natural, non-chemical supplements are highly effective at preventing disease, as well as treating a variety of medical issues. These issues can range from treating mild fatigue or a headache to treating full-blown cancer.

By taking the right supplements in accordance with a healthy lifestyle consisting of exercise and smart food choices, your health is guaranteed to improve.

Supplements can also help you improve your performance. If you’re an athlete and need your body to be in peak physical condition, or you’re trying to build muscle, or perhaps you just want to be able to think more clearly because finals are coming up, biopharmaceutical nutritional supplements can make a huge difference.

If you’re looking to improve your health, contact Sunshine Biopharma Nutrition, one of the most promising emerging biopharma companies, and let us advise you on the best supplements to suit your lifestyle and health goals.

Why Should You Buy Nutritional Supplements Online

If you’re looking for an organic way to boost your health but do not have the time or access needed to buy the items in a store physically, you might want to buy products such as amino acid supplements online.

There are numerous benefits to purchasing nutritional supplements online. We’ll list a few of them here.

It’s Good For Your Health

When taken correctly, nutritional supplements are highly beneficial to overall health. In addition, they can help treat various ailments in the medium to long term, minimizing the need for potentially harmful and expensive pharmaceuticals.

Whether you’re buying essential amino acids supplements online to boost your athletic performance, or whether you’re looking to take some extra vitamins and minerals to help your body thrive during pregnancy, nutritional supplements are a fantastic way to get your body everything it needs ‒ mainly when your lifestyle means that you don’t get enough through your normal day-to-day.

It’s Easier

Online shopping is a fast-growing market for several good reasons.

  1. The convenience of shopping online is second to none—no more traffic, queues, parking, carrying bags or finding the time. You can simply order from your sofa and have it delivered to your front door within days.
  2. The variety available in online stores often far outstrips the stock available in brick-and-mortar stores. As a result, you have a much better chance of finding what you’re looking for than in local physical shops.
  3. The prices online are usually better than those offered by brick-and-mortar operations due to online stores’ lower overheads. As a result, you’re much more likely to find bargains and lower online prices.
  4. The cost involved in physical shopping trips is rarely considered, but it is noticeable compared to online shopping. The next time you shop in person, calculate your fuel usage, the wear and tear on the car, the cost of parking and extras, and add it to the item’s price. Online shopping negates that, saving you money and valuable time.

To buy nutritional supplements such as amino acid supplements online, contact Sunshine Biopharma Nutrition today and place your order!

Tips For Taking Nutritional Supplements Correctly

In today’s world of unprecedented access to information, you may have come across a plethora of recommendations, blogs and advice about managing your nutrition to maximize your health and wellness. However, there is so much conflicting, inaccurate and misleading information.  

Rather than seeking anecdotal opinions from armchair pharmacists and self-styled nutritionists on social media, we at Sunshine Biopharma Nutrition are poised and ready to offer objective, accurate and science-based nutritional advice to get the right supplements for you to meet your unique needs.

The truth is, it’s tough to get all the nutrients you need every day from your diet alone. For example, consuming up to nine servings of fruit and veggies daily is not feasible for most people. Therefore, supplements can genuinely be your friend, only if you’re doing it right.

Let’s take a look at essential factors that you should keep in mind when taking nutritional supplements:

Dosage

Many people think that an overdose of vitamins, minerals, and amino acids is essentially harmless. But, at worst, you might be wasting your money. 

However, this is not entirely true. Depending on the substance and the dose, overdosing on certain supplements can have measurably adverse medical side effects, ranging from nausea and diarrhea to permanent liver damage.

Therefore, make sure to follow the dosage recommendations provided by the supplier or your pharmacist closely. Nutritional supplements can have significant health benefits if taken at the correct recommended dosage.

Directions

Aside from taking the correct dosage, you also need to be aware of how the supplement might interact with other medications you might be taking and your current diet. For example, sometimes unwanted side effects may occur if certain chemicals are mixed in your body. 

To get the most out of your nutritional supplements, you want to ensure that nothing else you’re consuming interferes with them, limiting their effectiveness.

Moreover, some supplements are best absorbed on a full stomach, while some should be taken on an empty stomach for the best results. Some are better taken at night, some are better taken in the morning, while some should be taken more than once a day. Ensure you follow the directions given regarding when to take the supplement and how. 

Storage

Make sure you store your supplements properly. Like any other kind of medicine, improper storage can lead to the supplements prematurely spoiling, resulting in them becoming less effective and potentially harmful. Although they have a long shelf life, like any spoiled consumable substance, spoiled supplements can potentially even make you sick – so be careful and responsible with how they’re stored.

For all your supplement needs, including science-based nutritional advice and expertise, contact Sunshine Biopharma Nutrition today!

Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells

A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments

Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a biopharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that two of its newly designed mRNA molecules are effective at destroying cancer cells grown in culture.

The cytotoxicity tests were performed on a variety of cancer cells including multidrug resistant breast cancer cells (MCF-7/MDR), ovarian adenocarcinoma cells (OVCAR-3), and pancreatic cancer cells (SUIT-2). Toxicity studies using non-transformed (normal) human cells (HMEC cells) showed that these mRNA molecules had little or no cytotoxic effects. These new mRNA molecules are readily adaptable for delivery into patients using the mRNA vaccine technology. The Company anticipates filing a patent application in connection with these results soon.

“We are delighted by these findings in connection with our ongoing mRNA-as-therapeutic-agents research,” said Dr. Steve Slilaty, CEO of Sunshine Biopharma. “The potential use of mRNA to treat cancer opens the door to many possibilities for patients including convenience, reduced toxicity and enhanced efficacy,“ he added.

About Sunshine Biopharma

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic that has claimed the lives of over 6.1 million people worldwide since it first appeared in December 2019. Sunshine Biopharma is working on the development of a treatment for COVID-19 and has completed the synthesis of four potential inhibitors of PLpro and subsequently identified a lead compound, SBFM-PL4. In addition, the Company recently expanded its research efforts into finding other PLpro inhibitors by entering into a collaboration agreement with the University of Arizona. The collaboration is focused on determining the in vivo safety, pharmacokinetics, and dose selection properties of three University of Arizona owned PLpro inhibitors, followed by efficacy testing in mice infected with SARS-CoV-2. The Company

holds the first option to negotiate for a commercial, royalty-bearing license for all intellectual property developed by University of Arizona under the research project.

In addition to working on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development of Adva-27a, a unique anticancer compound. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University’s Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.

Cautionary Note Regarding Forward Looking Statements

This press release and statements of the Company’s management made in connection therewith contain “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events. Words such as “may”, “could”, “expects”, “projects,” “intends”, “plans”, “believes”, “predicts”, “anticipates”, “hopes”, “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements appear in a number of places in this release and include all statements that are not statements of historical fact. These statements involve known and unknown risks and are based upon several assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the Company’s control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors described in the Company’s filings with the SEC. The Company’s SEC filings can be obtained free of charge on the SEC’s website at www.sec.gov. Except to the extent required by law, Sunshine Biopharma, Inc. (the “Company”) expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based.

For Additional Information:

Sunshine Biopharma Media Contacts: TraDigital IR
Direct Line: 917-633-8980 [email protected]

Sunshine Biopharma Inc. Contacts: Camille Sebaaly, CFO
Direct Line: 514-814-0464 [email protected] www.sunshinebiopharma.com

Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market

MONTREAL, Canada, Feb. 17, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc.

(NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical
company focused on the research, development and commercialization of oncology and antiviral
drugs, announced today the closing of its underwritten public offering of 1,882,353 units at a price
to the public of $4.25 per unit, for aggregate gross proceeds of $8 million, prior to deducting
underwriting discounts, commissions and other estimated offering expenses. Each unit consists of
one share of common stock, par value $0.001 per share, and two warrants, each warrant exercisable
for one share of common stock with an exercise price of $4.25.

In addition, the Company has granted Aegis Capital Corp. (“Aegis”) a 45-day option to purchase
additional shares of common pharmaceutical stock and/or warrants equal up to 15% of the number of shares and
warrants, respectively, sold in the offering solely to cover over-allotments, if any. The underwriter
partially exercised its over-allotment option with respect to 337,494 warrants to purchase shares of
common stock. At the closing, the Company issued an aggregate of 1,882,353 common shares and
4,102,200 warrants to purchase common shares.

The Company’s common stock and warrants are listed on the Nasdaq Capital under the symbols
“SBFM” and “SBFMW”, respectively.

Aegis Capital Corp. acted as sole book-running manager for the offering.
A registration statement on Form S-1 (No. 333-259394) relating to the securities being sold in this
offering was declared effective by the Securities and Exchange Commission (the “SEC”) on
February 14, 2022. The offering has been made only by means of a prospectus. Copies of the final
prospectus may be obtained on the SEC’s website, www.sec.gov, or by contacting Aegis Capital
Corp., Attention: Syndicate Department, 810 7th Avenue, 18th Floor, New York, NY 10019, by
email at [email protected], or by telephone at (212) 813-1010.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall
there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or
sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.

About Sunshine Biopharma
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the
ongoing COVID-19 pandemic that has claimed the lives of over 5.3 million people worldwide since
it first appeared in December 2019. There are currently no drugs that can effectively arrest
replication of the virus in people who have contracted the illness. Sunshine Biopharma has
completed the synthesis of four potential inhibitors of PLpro and subsequently identified a lead
compound, SBFM-PL4. The Company is currently advancing the development of SBFM-PL4 in
collaboration with the University of Georgia, College of Pharmacy.

In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is
engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date
have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells,
including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine
Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill
University’s Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all
patents and intellectual property pertaining to Adva-27a.

Safe Harbor Forward-Looking Statements
This press release may contain forward looking statements which are based on current expectations,
forecasts, and assumptions that involve risks as well as uncertainties that could cause actual
outcomes and results to differ materially from those anticipated or expected. These statements
appear in a number of places in this release and include all statements that are not statements of
historical fact regarding the intent, belief or current expectations of the Company, including
statements related to our financial performance and future growth. These risks and uncertainties are
further defined in filings and reports by the Company with the U.S. Securities and Exchange
Commission (SEC). Actual results and the timing of certain events could differ materially from
those projected in or contemplated by the forward-looking statements due to a number of factors
detailed from time to time in our filings with the SEC. Reference is hereby made to cautionary
statements and risk factors set forth in the Company’s most recent SEC filings.

For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
[email protected]
www.sunshinebiopharma.com

Sunshine Biopharma Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market

MONTREAL, Canada, Feb. 15, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc.
(NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a biopharmaceutical
company focused on the research, development and commercialization of oncology and antiviral
drugs, announced today the pricing of its underwritten public offering of 1,882,353 units at a price
to the public of $4.25 per unit, for aggregate gross proceeds of $8 million, prior to deducting
underwriting discounts, commissions and other estimated offering expenses. Each unit consists of
one share of common stock, par value $0.001 per share, and two warrants, each warrant exercisable
for one share of common stock. The common stock and warrants are immediately separable from
the Units and will be issued separately. The warrants are exercisable immediately, expire five years
from the date of issuance and have an exercise price of $4.25.

In addition, the Company has granted Aegis Capital Corp. (“Aegis”) a 45-day option to purchase
additional shares of common stock and/or warrants equal up to 15% of the number of shares and
warrants, respectively, sold in the offering solely to cover over-allotments, if any. The purchase price
to be paid per additional share of common stock will be equal to the public offering price of one
unit (in each case, less $0.01 allocated to the warrants), less the underwriting discount. The purchase
price to be paid per additional warrant will be $0.01. If Aegis exercises the option to purchase only
such warrants, additional proceeds will be nominal. If Aegis exercises the option in full for common
stock and warrants, the total gross proceeds of the offering including the overallotment are expected
to be approximately $9.2 million before deducting underwriting discounts and commissions and
offering expenses. The offering is expected to close on or about February 17, 2022, subject to
customary closing conditions.

The Company also announced that, in connection with the offering, its common stock and warrants
have been approved for listing on the Nasdaq Capital Market and will begin trading on the Nasdaq
Capital Market under the symbols “SBFM” and “SBFMW” on February 15, 2022.
Aegis Capital Corp. is acting as sole book-running manager for the offering.
A registration statement on Form S-1 (No. 333-259394) relating to the securities being sold in this
offering was declared effective by the Securities and Exchange Commission (the “SEC”) on
February 14, 2022. The offering is being made only by means of a prospectus. Copies of the final
prospectus may be obtained, when available, on the SEC’s website, www.sec.gov, or by contacting
Aegis Capital Corp., Attention: Syndicate Department, 810 7th Avenue, 18th Floor, New York, NY
10019, by email at [email protected], or by telephone at (212) 813-1010.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall
there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or
sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.

About Sunshine Biopharma
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the
ongoing COVID-19 pandemic that has claimed the lives of over 5.3 million people worldwide since
it first appeared in December 2019. There are currently no drugs that can effectively arrest
replication of the virus in people who have contracted the illness. Sunshine Biopharma has
completed the synthesis of four potential inhibitors of PLpro and subsequently identified a lead
compound, SBFM-PL4. The Company is currently advancing the development of SBFM-PL4 in
collaboration with the University of Georgia, College of Pharmacy.

In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is
engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date
have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells,
including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine
Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill
University’s Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all
patents and intellectual property pertaining to Adva-27a.

Safe Harbor Forward-Looking Statements
This press release may contain forward looking statements which are based on current expectations,
forecasts, and assumptions that involve risks as well as uncertainties that could cause actual
outcomes and results to differ materially from those anticipated or expected. These statements
appear in a number of places in this release and include all statements that are not statements of
historical fact regarding the intent, belief or current expectations of the Company, including
statements related to the closing of the offering, our financial performance, and future growth.
These risks and uncertainties are further defined in filings and reports by the Company with the U.S.
Securities and Exchange Commission (SEC). Actual results and the timing of certain events could
differ materially from those projected in or contemplated by the forward-looking statements due to
a number of factors detailed from time to time in our filings with the SEC. Reference is hereby
made to cautionary statements and risk factors set forth in the Company’s most recent SEC filings.

For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
[email protected]
www.sunshinebiopharma.com

What Are Bio Pharmaceuticals And Why Do Our Bodies Need Them?

Since their development, biopharmaceuticals have enhanced the quality of life in patients with various diseases. They can also help replenish the amino acids and vitamins we need from our diets but don’t always get in the proper doses. Amino acids are organic compounds that help to break down your food into the fuel you need. In this article, we take a closer look at what biopharmaceuticals are and how they can fuel our bodies to keep up with the demands of daily living.

BIO PHARMACEUTICALS VS REGULAR PHARMACEUTICALS

In broad terms, biopharmaceuticals are defined as pharmaceuticals that are inherently biological and produced using biotechnology. Their structure is identical to compounds already found in nature. They contain live entities and can include proteins, DNA  RNA, or antisense oligonucleotides for therapeutic purposes. However, they can be challenging to manufacture and require specialized and expensive processing and purification methods. In short, biopharmaceuticals are derived from living organisms. In contrast, pharmaceutical drugs are made from chemicals and synthetic processes rather than natural ones.

WHY BIO IS BETTER FOR OUR BODIES

One of the benefits of biopharmaceuticals is that they provide targeted treatment with fewer side effects, devoid of chemicals. Patients with cancer, diabetes, cardiovascular disease, immune diseases, and other health problems benefit from this. Being healthy requires a balanced diet, physical activity, and general wellness. Amino acids are organic compounds that help to fuel us by breaking down our food and building proteins. Vitamins and minerals also help with healthy bodily functions and boost our immune systems, as well as repairing cell damage. Since our bodies cannot produce these amino acids and vitamins, biopharmaceuticals are a great source of these essential nutrients.

Ideally, a healthy diet should provide everything our bodies need, but it doesn’t always happen that way, as time, stress and resources sometimes prevent us from eating well. Even if we manage to eat balanced meals from time to time, there may still be some shortfall, which would have to be replaced with a supplement. Illnesses can also drain us of energy and affect our appetites, so biopharmaceutical products provide a safe alternative for the missing nutrients with little to no side effects.

GIVE YOUR BODY THE FUEL IT NEEDS.

Whether you want to boost your immune system, increase your protein intake and build muscle, or explore meal replacement options, Sunshine Biopharma Nutrition has the solution. All of our products are backed by science. We are continually engaged in the development and commercialization of science-based nutritional supplements. For a healthy dietary supplement, contact us here or call 514-426-6161.